WST - West Pharmaceutical Services, Inc.
NEXT EARNINGS:
Apr 23, 2026
EPS Est: $1.68
|
Rev Est: $779.5M
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$303.33
DETAILS
HIGH:
$340.00
LOW:
$265.00
MEDIAN:
$305.00
CONSENSUS:
$303.33
UPSIDE:
27.97%
Market Cap:
17.07B
Volume:
215,992
Avg Volume:
944,772
52 Week Range:
187.43-322.34
Sector:
Healthcare
Industry:
Medical - Instruments & Supplies
Beta:
1.18
Last Dividend:
$0.86
Exchange:
NYSE
Country:
US
Employees:
10,600
IPO Date:
1980-03-17
EPS (TTM):
6.83
P/E Ratio:
40.29
Revenue (TTM):
3.07B
Total Assets:
4.27B
Total Debt:
416.70M
Cash & Equiv:
791.30M
Rev Growth (5Y):
7.4%
EPS Growth (5Y):
7.9%
FCF Growth (5Y):
9.5%
ROCE:
16.6%
Debt/Equity:
0.13
Earnings History
| Date | EPS Actual | EPS Est | EPS Surprise | Rev Actual | Rev Est | Rev Surprise |
|---|---|---|---|---|---|---|
| 2026-02-12 | $2.04 | $1.83 | +11.5% | $805.0M | $794.9M | +1.3% |
| 2025-10-23 | $1.96 | $1.68 | +16.7% | $804.3M | $785.7M | +2.4% |
| 2025-07-24 | $1.84 | $1.51 | +21.9% | $766.2M | $726.1M | +5.5% |
| 2025-04-24 | $1.45 | $1.22 | +18.9% | $698.0M | $713.0M | -2.1% |
| 2025-02-13 | $1.82 | $1.71 | +6.4% | $748.8M | $740.5M | +1.1% |
| 2024-10-24 | $1.85 | $1.50 | +23.3% | $746.9M | $709.6M | +5.3% |
| 2024-07-25 | $1.52 | $1.74 | -12.6% | $702.0M | $729.4M | -3.8% |
| 2024-04-25 | $1.56 | $1.26 | +23.8% | $695.4M | $670.6M | +3.7% |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 3.07B | 2.89B | 2.95B | 2.89B | 2.83B | 2.15B | 1.84B | 1.72B | 1.60B | 1.51B | 1.40B | 1.42B |
| Net Income | 493.70M | 492.70M | 593.40M | 585.90M | 661.80M | 346.20M | 241.70M | 206.90M | 150.70M | 143.60M | 95.60M | 127.10M |
| EPS | 6.83 | 6.75 | 7.99 | 7.88 | 8.90 | 4.68 | 3.27 | 2.80 | 2.04 | 1.96 | 1.33 | 1.79 |
| Total Assets | 4.27B | 3.64B | 3.83B | 3.62B | 3.31B | 2.79B | 2.34B | 1.59B | 1.86B | 1.72B | 1.70B | 1.67B |
| Total Debt | 416.70M | 305.30M | 309.00M | 317.90M | 325.30M | 325.70M | 329.30M | 196.10M | 197.00M | 228.60M | 298.20M | 335.50M |
| Cash & Equivalents | 791.30M | 484.60M | 853.90M | 894.30M | 762.60M | 615.50M | 439.10M | 337.40M | 235.90M | 203.00M | 274.60M | 255.30M |
| Operating Cash Flow | 754.80M | 653.40M | 776.50M | 724.00M | 584.00M | 472.50M | 367.20M | 288.60M | 263.30M | 219.40M | 212.40M | 182.90M |
| Free Cash Flow | 468.90M | 276.40M | 414.50M | 439.40M | 330.60M | 298.10M | 240.80M | 183.90M | 132.50M | 49.20M | 80.80M | 70.80M |
| FCF per Share | 6.49 | 3.79 | 5.58 | 5.91 | 4.44 | 4.03 | 3.25 | 2.49 | 1.79 | 0.67 | 1.12 | 1.00 |
| Book Value | 3.18B | 2.68B | 2.88B | 2.68B | 2.34B | 1.85B | 1.57B | 1.40B | 1.28B | 1.12B | 1.02B | 956.90M |
| Cash & ST Investments | 791.30M | 484.60M | 853.90M | 894.30M | 762.60M | 615.50M | 439.10M | 337.40M | 235.90M | 203.00M | 274.60M | 255.30M |
| ROC Equity | 0.16 | 0.18 | 0.21 | 0.22 | 0.28 | 0.19 | 0.15 | 0.15 | 0.12 | 0.13 | 0.09 | 0.13 |